Nextech Invest Ag Cullinan Oncology, Inc. Transaction History
Nextech Invest Ag
- $613 Million
- Q3 2024
A detailed history of Nextech Invest Ag transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Nextech Invest Ag holds 1,141,145 shares of CGEM stock, worth $15.8 Million. This represents 3.12% of its overall portfolio holdings.
Number of Shares
1,141,145
Previous 1,221,145
6.55%
Holding current value
$15.8 Million
Previous $21.3 Million
10.3%
% of portfolio
3.12%
Previous 4.02%
Shares
2 transactions
Others Institutions Holding CGEM
# of Institutions
146Shares Held
67.6MCall Options Held
612KPut Options Held
118K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$106 Million19.97% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$79.7 Million3.06% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$49.2 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$47.3 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.28MShares$45.5 Million1.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $632M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...